1. Home
  2. BLZE vs FTH Comparison

BLZE vs FTH Comparison

Compare BLZE & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

BUY

Current Price

$9.12

Market Cap

762.0M

Sector

Technology

ML Signal

BUY

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

BUY

Current Price

$19.44

Market Cap

835.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BLZE
FTH
Founded
2007
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
762.0M
835.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
BLZE
FTH
Price
$9.12
$19.44
Analyst Decision
Buy
Strong Buy
Analyst Count
7
16
Target Price
$22.83
★ $56.14
AVG Volume (30 Days)
★ 1.6M
331.0K
Earning Date
11-02-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.56
N/A
EPS
★ N/A
N/A
Revenue
★ $145,835,000.00
N/A
Revenue This Year
$18.60
N/A
Revenue Next Year
$25.89
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.27
N/A
52 Week Low
$3.26
$17.50
52 Week High
$23.99
$42.14

Technical Indicators

Market Signals
Indicator
BLZE
FTH
Relative Strength Index (RSI) 27.06 29.10
Support Level $3.53 N/A
Resistance Level $9.46 $36.63
Average True Range (ATR) 0.81 2.32
MACD -0.48 -0.72
Stochastic Oscillator 10.50 11.64

Price Performance

Historical Comparison
BLZE
FTH

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Share on Social Networks: